CAS NO: | 1239269-51-2 |
包装 | 价格(元) |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
生物活性 | Henatinib is an orally active small-molecule multikinase inhibitor that has demonstrated broad and potent antitumor activities. Henatinib inhibits the activity ofVEGFR-2,c-kit,PDGFRwithIC50values of 0.6 nM, 3.3 nM and 41.5 nM, respectively. Henatinib significantly inhibits VEGFR-2 phosphorylation and its downstream signal pathway in human umbilical vein endothelial cells (HUVECs)[1]. | |||
IC50& Target |
| |||
体外研究 (In Vitro) | Henatinib shows high binding affinities for VEGFRs, PDGFR and stem cell factor receptor[1]. | |||
Clinical Trial | ||||
分子量 | 468.52 | |||
Formula | C25H29FN4O4 | |||
CAS 号 | 1239269-51-2 | |||
运输条件 | Room temperature in continental US; may vary elsewhere. | |||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |